We use cookies to customize content for your viewing and for analytics. If you continue to browse this website, we will assume that you are happy to receive all our cookies. For further information please read our cookie policy.
Rautio, R., Alpay, K., Sinisalo, M., & Numminen, J.
Treatment of Intracranial Aneurysms Using the New Surpass Evolve Flow Diverter: Safety Outcomes and Six-Month Imaging Follow-Up
78%
Favorable occlusion rate (OKM C-D) at 6 months
| Number of patients | 29 |
| Number of aneurysms | 30 |
| Major morbidity and mortality | 3% (1/30) |
| In-stent stenosis (≥50%) | 3% (1/34) |
Clinical Neuroradiology | 2020
Rautio, R., Alpay, K., Sinisalo, M., & Numminen, J. (2022). Treatment of intracranial aneurysms using the new Surpass Evolve flow diverter: Safety outcomes and six-month imaging follow-up. Journal of neuroradiology = Journal de neuroradiologie, 49(1), 80–86. https://doi.org/10.1016/j.neurad.2021.03.003
Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Stryker, Surpass Evolve. All other trademarks are trademarks of their respective owners or holders.
Information contained herein for use outside the US only.
AP004697 v1.0